Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Emel Unal, Derya Ozyoruk, Nurdan Tacyildiz, Ferda Pi̇narli̇, A Erdogan, S Hanalioglu, Arzu Erdem, Meral Beksac, MD

Blood (2019) 134 (Supplement_1): 5632.

https://doi.org/10.1182/blood-2019-130102

Published: 2019

Journal Articles

Newly Identified Metabolites Connect Colon Cancer to Thrombosis

Mostafa Belghasem, MD PhD, Daniel Michael Roth, MSc, BSc, Joshua Aaron Walker, PhD, Sean Richards, Cheryl Spencer, Joseph Yeghishe Tashijan, BSc, Nkriuka Arinze, MD, Chris Andry, MPhil, PhD, Katya Ravid, PhD DSc, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 78.

https://doi.org/10.1182/blood-2018-99-113680

Published: 2018

Journal Articles

Myc Regulates the Development and Anti-Tumor Immunity of Natural Killer Cells

Yuting Tang, MD PhD, Xiaomei Yan, MD PhD, Di Zhan, PhD, Lijun Wen, MS, Rui Huang, MD PhD, Yue Zhang, MD PhD, Yoshihiro Hayashi, MD PhD, Qianfei Wang, PhD, Jianfeng Zhou, MD PhD, Gang Huang, PhD

Blood (2018) 132 (Supplement 1): 1113.

https://doi.org/10.1182/blood-2018-99-114180

Published: 2018

Journal Articles

Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis

Allison S. Remiker, MD, Leah A. Rosenfeldt, BS, Greg N. Adams, PhD, Matthew J. Flick, PhD, Malinda D. Frederick, BS, Joseph S. Palumbo, MD

Blood (2017) 130 (Supplement 1): 1063.

https://doi.org/10.1182/blood.V130.Suppl_1.1063.1063

Published: 2017

Journal Articles

90 Yttrium-Ibritumomab Tiuxetan as First Line Treatment for Follicular Non-Hodgkin Lymphoma. 5 Year Results from an International Multicenter Phase II Clinical Trial

Kristina Lerch, Corinna Leng, Antonello Pinto, Werner Linkesch, Heinz Sill, Ola Linden, Andreas Viardot, Ulrich Keller, Georg Hess, MD, Secondo Lastoria, Ferdinando Frigeri, Nicole Neik, Christiane Pott, Christian W. Scholz, Antonio Pezzutto, MD PhD

Blood (2016) 128 (22): 1806.

https://doi.org/10.1182/blood.V128.22.1806.1806

Published: 2016

Journal Articles

Solid Tumors in Patients with Chronic Lymphocytic Leukemia Who Received Frontline Lenalidomide Therapy: Distribution and Clinical Outcomes

Ahmad Alhuraiji, MD MRCP, Lorenzo Falchi, MD, Michael Keating, MBBS, Zeev Estrov, MD, Paolo Strati, MD, William Wierda, MD PhD, Nitin Jain, MD, Philip A Thompson, MBBS, Alessandra Ferrajoli, MD

Blood (2016) 128 (22): 5573.

https://doi.org/10.1182/blood.V128.22.5573.5573

Published: 2016

Journal Articles

Lenalidomide Maintenance after Autologous Stem Cell Transplant in Patients with High-Risk Relapsed/Refractory Lymphomas Is Feasible and Compares Favorably to Historical Controls: Results of a Phase I/II Trial

Jakub Svoboda, MD, Lauren E. Strelec, BA, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Anthony R. Mato, MD, Wei-Ting Hwang, PhD, Sarah Jordan Nagle, MD, Elise A. Chong, MD, Samantha Garrett, Terease S. Waite, MS, RN, JD, MBE, Ellen Napier, NP, Stephen J. Schuster, MD

Blood (2016) 128 (22): 4639.

https://doi.org/10.1182/blood.V128.22.4639.4639

Published: 2016

Journal Articles

Lenalidomide in Combination with R-ESHAP (LR-ESHAP) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Are Candidates for Autologous Stem-Cell Transplantation: A Phase 2 Study from the Spanish Group Geltamo

Alejandro Martín, MD PhD, Mónica Baile, MD, Guillermo Rodríguez, MD, Ivan Dlouhy, MD, Juan Manuel Sancho, MD PhD, Isidro Jarque, MD, Eva González-Barca, MD PhD, Antonio Salar, MD PhD, Manuel Espeso, Carlos Grande, MD PhD, Juan Bergua, MD, Santiago Montes-Moreno, MD, Armando Lopez-Guillermo, Dolores Caballero, MD PhD

Blood (2016) 128 (22): 1850.

https://doi.org/10.1182/blood.V128.22.1850.1850

Published: 2016

Journal Articles

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Aref Al-Kali, MD, Michelle Elliott, MD, Mark R. Litzow, MD, Naseema Gangat, MBBS, Curtis A. Hanson, MD, Ayalew Tefferi, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 1989.

https://doi.org/10.1182/blood.V128.22.1989.1989

Published: 2016

Journal Articles

Comparative Effectiveness and Safety of Direct Oral Anticoagulants (DOAC) Versus Conventional Anticoagulation for the Treatment of Cancer-Related Venous Thromboembolism: A Retrospective Analysis

Jeremy A Ross, MD, Marilyn Miller, MSN-RN, FNP-C, Cristhiam M Rojas Hernandez, MD

Blood (2015) 126 (23): 1123.

https://doi.org/10.1182/blood.V126.23.1123.1123

Published: 2015

Journal Articles

Efficacy and Toxicity of Nucleoside Analogs in Patients with Hairy Cell Leukemia Treated Outside Clinical Trials

Maria Luisa Guerrera, MD, Marzia Varettoni, MD, Alessandra Tedeschi, MD, Anna Maria Frustaci, MD, Virginia Valeria Ferretti, PhD, Luca Arcaini, Prof, Paola Picardi, MD, Silvia Zibellini, Sara Rattotti, MD, Roberto Cairoli, MD, Mario Cazzola, MD

Blood (2015) 126 (23): 5084.

https://doi.org/10.1182/blood.V126.23.5084.5084

Published: 2015

Journal Articles

Thrombin Drives Colorectal Cancer Pathogenesis at the Level of Primary Tumor Growth, Tumor Invasion and Metastasis

Gregory N Adams, PhD, Dusty Waltz, Leah Rosenfeldt, Malinda Frederick, Whitney Miller, Alexey S Revenko, PhD, Brett P. Monia, PhD, Joseph S. Palumbo, MD

Blood (2014) 124 (21): 2812.

https://doi.org/10.1182/blood.V124.21.2812.2812

Published: 2014

Journal Articles

Lenalidomide and Rituximab in Combination As Initial Treatment of Chronic Lymphocytic Leukemia: Initial Results of a Phase II Study

Philip A Thompson, Michael J Keating, MBBS, Christina Hinojosa, Susan C. Smith, Naval G. Daver, MD, Nitin Jain, MD, Jan A. Burger, MD PhD, Zeev Estrov, MD, Susan O'Brien, MD, William G. Wierda, MD PhD, Hagop M. Kantarjian, MD, Alessandra Ferrajoli, MD

Blood (2014) 124 (21): 1988.

https://doi.org/10.1182/blood.V124.21.1988.1988

Published: 2014

Journal Articles

The Role of DNA Repair in the Pathogenesis of Activation Induced Cytidine Deaminase Dependent B Cell Lymphoma

Xiwen Gu, Ph.D., Carmen J. Booth, D.V.M., Ph.D., David G. Schatz, Ph.D., Matthew P. Strout, M.D., Ph.D.

Blood (2011) 118 (21): 397.

https://doi.org/10.1182/blood.V118.21.397.397

Published: 2011

Journal Articles

Correction of the Fanconi Anemia Phenotype at the Cellular Level by S Phase Delay: Implications for Etiopathogenesis and Treatment

W. Clark Lambert, MD, PhD, Santiago Centurion, MD, Monique Brown

Blood (2010) 116 (21): 879.

https://doi.org/10.1182/blood.V116.21.879.879

Published: 2010

Journal Articles

90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma. First Results from an International Phase II Clinical Trial

Christian W. Scholz, MD, Antonello Pinto, MD, Werner Linkesch, MD, Ola Linden, MD, Andreas Viardot, MD, Ulrich Keller, MD, Georg Hess, MD, Kristina Lerch, MD, Ferdinando Frigeri, MD, Manuela Arcamone, MD, Bernd Frericks, MD, Christiane Pott, MD, Antonio Pezzutto

Blood (2010) 116 (21): 593.

https://doi.org/10.1182/blood.V116.21.593.593

Published: 2010

Journal Articles

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Birgit Burkhardt, MD, PhD, Alfred Reiter, MD, Eva Landmann, MD, Peter J. Lang, MD, Lisa Lassay, MD, Roswitha Dickerhoff, MD, Max Lakomek, MD, Guenter Henze, MD, Arend von Stackelberg, MD

Blood (2008) 112 (11): 3589.

https://doi.org/10.1182/blood.V112.11.3589.3589

Published: 2008

Journal Articles

Frequency and Prognostic Relevance of Cancer Testis Antigen 45 Expression in Multiple Myeloma

Valeria C.C. Andrade, Gisele W. B. Colleoni, Andre Luiz Vettore, Maria R. R. Silva, Roberta Spetic Felix, Manuella Sampaio Almeida, Fabricio Carvalho, Marco A. Zago, Otavia L. Caballero, Andrew J. Simpson

Blood (2008) 112 (11): 5134.

https://doi.org/10.1182/blood.V112.11.5134.5134

Published: 2008

Journal Articles

High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).

K.-John Cheung, MSc, Adele Telenius, Betty Lai, Nathalie Johnson, MD, Thomas Relander, MD, Christian Steidl, MD, Agnes Baross, PhD, Hong Qian, Jacquie Schein, PhD, Marco Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Douglas E. Horsman, MD

Blood (2007) 110 (11): 183.

https://doi.org/10.1182/blood.V110.11.183.183

Published: 2007

Journal Articles

Using Recombinant Activated Factor VII (rFVIIa) in Refractory Bleeding: A Community Hospital Experience.

Alaa Muslimani, MD, Hamed Daw, M.D

Blood (2006) 108 (11): 4048.

https://doi.org/10.1182/blood.V108.11.4048.4048

Published: 2006

NARROW

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Newly Identified Metabolites Connect Colon Cancer to Thrombosis

Myc Regulates the Development and Anti-Tumor Immunity of Natural Killer Cells

Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis

90 Yttrium-Ibritumomab Tiuxetan as First Line Treatment for Follicular Non-Hodgkin Lymphoma. 5 Year Results from an International Multicenter Phase II Clinical Trial

Solid Tumors in Patients with Chronic Lymphocytic Leukemia Who Received Frontline Lenalidomide Therapy: Distribution and Clinical Outcomes

Lenalidomide Maintenance after Autologous Stem Cell Transplant in Patients with High-Risk Relapsed/Refractory Lymphomas Is Feasible and Compares Favorably to Historical Controls: Results of a Phase I/II Trial

Lenalidomide in Combination with R-ESHAP (LR-ESHAP) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Are Candidates for Autologous Stem-Cell Transplantation: A Phase 2 Study from the Spanish Group Geltamo

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Comparative Effectiveness and Safety of Direct Oral Anticoagulants (DOAC) Versus Conventional Anticoagulation for the Treatment of Cancer-Related Venous Thromboembolism: A Retrospective Analysis

Efficacy and Toxicity of Nucleoside Analogs in Patients with Hairy Cell Leukemia Treated Outside Clinical Trials

Thrombin Drives Colorectal Cancer Pathogenesis at the Level of Primary Tumor Growth, Tumor Invasion and Metastasis

Lenalidomide and Rituximab in Combination As Initial Treatment of Chronic Lymphocytic Leukemia: Initial Results of a Phase II Study

The Role of DNA Repair in the Pathogenesis of Activation Induced Cytidine Deaminase Dependent B Cell Lymphoma

Correction of the Fanconi Anemia Phenotype at the Cellular Level by S Phase Delay: Implications for Etiopathogenesis and Treatment

90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma. First Results from an International Phase II Clinical Trial

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Frequency and Prognostic Relevance of Cancer Testis Antigen 45 Expression in Multiple Myeloma

High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).

Using Recombinant Activated Factor VII (rFVIIa) in Refractory Bleeding: A Community Hospital Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only